On-Demand Webinars

  1. The Evolving Policy Landscape: U.S. And EU Pricing And Access 5/20/2026

    U.S. and EU policy shifts are reshaping pricing, access, and launch strategy. Hear expert analysis on IRA, MFN, 340B, EU HTA Regulation, and the Biotech Act to stay ahead of 2025-2026 changes.

  2. Building The Right Foundation - Live Cell Assays In Clinical Trials 5/19/2026

    Watch Thomas (TJ) Beadnell share expert insights on developing robust live cell assays for global clinical trials, including best practices for assay logistics, antigen stability, and sample integrity.

  3. A Blueprint For Clinical-Grade Gene Therapy Production 5/19/2026

    View a scalable, open-access AAV9 manufacturing process improving yield, purity, and consistency through optimized transfection and downstream purification for clinical-grade gene therapy production.

  4. Evaluating The Entire Package System Under USP 382 5/18/2026

    USP 382 introduces holistic packaging evaluation, focusing on container closure integrity, functionality, and real-world conditions to ensure sterility, safety, and product reliability.

  5. Understanding The Regulatory Landscape For Ophthalmic Drug Products 5/14/2026

    Learn how evolving ophthalmic regulations, contamination control strategies, and advanced packaging solutions can help support compliance, product quality, and patient safety.

  6. Strategic Early Material Generation For Accelerated Process Development 5/14/2026

    Learn how early material generation strategies can accelerate biologics development, streamline process optimization, and enable scalable, production-relevant material supply from the earliest stages of development.

  7. Foundations And Implications For International Reference Pricing 5/14/2026

    Reforms like the U.S. Most Favored Nation model are intensifying pressure on global launch strategies. Understand the tactics that protect value while expanding access.

  8. The Growing Role Of Real-World Evidence 5/14/2026

    Regulators and HTA bodies are raising the bar on real-world evidence. Understand how JCAs, oncology registries, and EHR data are redefining what credible RWE looks like, and how to meet agency expectations.

  9. Optimizing Outcomes In ADC Manufacturing 5/13/2026

    As bioconjugates evolve, optimized conjugation and strong process and analytical strategies are essential for ensuring consistent quality, targeted characteristics, and reliable therapeutic performance.

  10. Design Scalable Downstream Processes With Practical Strategies 5/11/2026

    Downstream purification is becoming more complex as new modalities enter development. Learn how advanced analytics and chromatography strategies can support scalable, confident process development.